| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.19 | 0.006 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.007 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.46 | 0.008 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |